A blinded, randomized and controlled multicenter clinical trial to assess the efficacy and safety of Leisguard® as an immunotherapeutic treatment for healthy Leishmania infantum-seropositive dogs

  1. Baxarias, M.
  2. Donato, G.
  3. Mateu, C.
  4. Salichs, M.
  5. Homedes, J.
  6. Miró, G.
  7. Pennisi, M.G.
  8. Solano-Gallego, L.
Zeitschrift:
Parasites & vectors

ISSN: 1756-3305

Datum der Publikation: 2023

Ausgabe: 16

Nummer: 1

Seiten: 344

Art: Artikel

DOI: 10.1186/S13071-023-05903-0 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus